Registry
Registry is an intervention with 39 clinical trials. Currently 15 active trials ongoing. Historical success rate of 61.5%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
57.1%
8 of 14 finished
42.9%
6 ended early
15
trials recruiting
39
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Brain, Blood And Clot or Tissue Registry And Collaboration
German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation
The Precision CAD Trial
Clinical Trials (39)
Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Brain, Blood And Clot or Tissue Registry And Collaboration
German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation
The Precision CAD Trial
Childhood Cancer Predisposition Study (CCPS)
Registry for CADASIL
BE.Amycon Registry UZ Leuven
Barts Endocarditis Research Registry
Proton Radiation Therapy Registry
Genotype-phenotype Association in Hereditary Hemorrhagic Telangiectasia
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Vermont Oxford Network Very Low Birth Weight Database
Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia
MAVRIC VR ICD Registry
ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
Cardiac Amyloidosis Registry Study
Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy
AIMS Academy Clinical Research Network - Non Metastatic Rectal Cancer Operated on With Curative Intent
Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-classification
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 39